Evidence map›Paper›PMID 35391944›Full record

ReviewJournal of bone oncology2022

State-of-the-art of minimally invasive treatments of bone metastases.

Cun Li, Qianghua Wu, Daijun Chang, Hui Liang, Xiaofei Ding, Chendeng Lao, Zonggui Huang

Open access · goldAbstract readReview
In one paragraph

Review in Journal of bone oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Cun LiDepartment of Orthopaedics, The First People's Hospital of Nanning, Nanning, PR China.
Qianghua WuDepartment of Orthopaedics, The First People's Hospital of Nanning, Nanning, PR China.
Daijun ChangDepartment of Orthopaedics, The First People's Hospital of Nanning, Nanning, PR China.
Hui LiangDepartment of Orthopaedics, The First People's Hospital of Nanning, Nanning, PR China.
Xiaofei DingDepartment of Orthopaedics, The First Affiliated Hospital of Guangxi Medical University, Nanning, PR China.
Chendeng LaoDepartment of Orthopaedics, The First People's Hospital of Nanning, Nanning, PR China.
Zonggui HuangDepartment of Orthopaedics, The First People's Hospital of Nanning, Nanning, PR China.
First People's Hospital of Nanning · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone metastases is a common manifestation of advanced malignant tumors. With the recent advances in medical technology, the survival period of patients with malignant tumors is prolonged, and the probability of bone metastases is significantly increased. Approximately 70% to 80% of patients with breast or prostate cancer will eventually develop bone metastases. In addition, thyroid, lung, and kidney carcinomas are all known to cause bone metastases, with a 30% to 40% incidence upon postmortem assessment. Bone metastases often lead to severe pain, pathological fractures, and nerve damage and have become a critical factor affecting the quality of life and life expectancy of cancer patients. Although treatments for bone metastases are diverse, choosing the appropriate treatment is difficult. Both conservative treatment and open surgery have certain drawbacks and may not be appropriate for all patients. Interventional procedures have the advantages of less trauma with quicker recovery and represent a viable alternative. This review provides updates on the progress of research on the interventional treatment of bone metastases and directions regarding relevant further studies.

Indexed as

Bone metastasesImage guidedInterventional treatmentMinimally invasive surgical technologyResearch progress

Identifiers

PMID35391944
PMCPMC8980625
OpenAlexW4220966838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.